Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?

Objective: To examine the efficacy and safety of non-pharmacological non-ablative options (or a combination these) for postmenopausal dyspareunia. Mechanism: Narrative review on Findings in Brief: Dyspareunia is most bothersome symptom genitourinary syndrome menopause, often complicated by decreased sexual interest arousal. Solid-state vaginal laser (SSVL) recombinant platelet-derived epidermal growth factors (RGFs) are new alternatives that improve female dysfunction resulting from Conclusions: SSVL alternative treatment dyspareunia either alone or with other similar to classical options.